Vaxart Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -54.2% | -90.9% | +280.0% | +742.9% | +12.3% | -24.6% | +55.3% | +38.0% | +48.6% | +2.6% | -3.1% | |
| – | +23.5% | -4.8% | -76.2% | +13.0% | +16.3% | +595.1% | +103.5% | +53.2% | +4.0% | -18.6% | -27.7% | |
| – | -89.9% | -5.0% | -118.8% | – | – | +435.4% | +172.4% | +50.3% | – | – | – | |
| – | -419.4% | – | -89.7% | +162.0% | -47.7% | +118.8% | -175.6% | – | – | – | -791.7% | |
| – | +0.0% | +100.0% | -41.5% | +504.3% | +20.2% | +43.9% | +321.7% | +86.2% | -80.5% | -70.4% | -73.8% | |
| – | +92.1% | – | +144.8% | +723.8% | -103.2% | +43.5% | +3,924.3% | -58.4% | – | -148.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -99.9% | +166.7% | -45.8% | +19,438.5% | +5,319.8% | -97.4% | +385.9% | -102.1% | – | – | |
| – | +200.0% | +33.3% | +335.5% | +0.0% | – | – | – | – | – | – | – | |
| – | -100.4% | – | -99.9% | -7,304.2% | – | +766.6% | -9.0% | -86.1% | -12.7% | +271.1% | -92.5% | |
| – | -348.3% | – | -236.7% | – | -79.7% | +5,511.1% | -85.1% | -679.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.